Zemplar and cough Patient Reports February 10, 2012

Zemplar Side Effects Report #4593074-9
Zemplar side effect was reported by a Consumer or non-health professional from on July 15, 2004. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with renal failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood pressure increased, chest discomfort, cough, dyspnoea, tachycardia. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA. Patient recovered.

Zemplar Side Effects Report #5856661-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 15, 2008. Male patient, 74 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cough, foot fracture, impaired healing, localised infection, resorption bone increased, respiratory moniliasis. Zemplar dosage: 5MCG/ML, 4ML/WEEK. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5886808-4
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 13, 2008. Male patient, 74 years of age, weighting 174.4 lb, was diagnosed with hyperparathyroidism secondary, gastric disorder, blood glucose increased, vitamin supplementation, thrombosis prophylaxis, blood disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arrhythmia , blood glucose increased, cerebrovascular accident, cough, exercise tolerance decreased, fatigue, foot fracture, gangrene, impaired healing. Zemplar dosage: 5MCG/ML, 4ML/WEEK. During the same period patient was treated with DIMETICONE, INSULIN, INSULIN GLARGINE, PARENTROVITE, VITAMIN E, CALCIUM CARBONATE, CLOPIDOGREL, ACETYL SALICYLIC ACID COMPOUND. Patient was hospitalized. Patient died on 08/29/2008.

Zemplar Side Effects Report #5900099-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 23, 2008. Male patient, 74 years of age, weighting 174.4 lb, was diagnosed with hyperparathyroidism secondary, gastric disorder, blood glucose increased, vitamin supplementation, thrombosis prophylaxis, blood disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arrhythmia , blood glucose increased, cerebrovascular accident, cough, exercise tolerance decreased, fatigue, foot fracture, gangrene, impaired healing. Zemplar dosage: 5MCG/ML, 4ML/WEEK. During the same period patient was treated with DIMETICONE, INSULIN, INSULIN GLARGINE, PARENTROVITE, VITAMIN E, CALCIUM CARBONATE, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient died on 08/29/2008.


Zemplar Side Effects Report #5080281-4
Zemplar side effect was reported by a Physician from GERMANY on Aug 04, 2006. Male patient, weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood culture positive, catheter sepsis, cough, pseudomonas infection, streptococcal infection , urinary tract infection . Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5088150-0
Zemplar side effect was reported by a Physician from GERMANY on Aug 04, 2006. Male patient, weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood culture positive, catheter sepsis, cough, pseudomonas infection, streptococcal infection , urinary tract infection . Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5117901-1
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Sept 05, 2006. Male patient, weighting 178.6 lb, was diagnosed with hyperparathyroidism secondary, hypercholesterolaemia, hypertension, insomnia, haemodialysis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anaemia, aortic arteriosclerosis, aortic dilatation, cardiomegaly, chest discomfort, cold sweat, cough, ejection fraction decreased, haematuria. Zemplar dosage: unknown. During the same period patient was treated with TORVACARD, TENOLOC, NITRENDIPINE, ZOREM, FUROSEMIDE, ALLOPURINOL, DIAZEPAM, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5810738-7
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on July 10, 2008. Female patient, weighting 184.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, phosphorus metabolism disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiogenic shock, cough, hypotension, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, FOLIC ACID, ACETYLSALICYLIC ACID SRT, TITRALAC, ACENOCOUMAROL, ALUCAP. Patient was hospitalized. Patient died on 07/09/2008.

Zemplar Side Effects Report #5830025-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on July 24, 2008. Female patient, weighting 184.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, phosphorus metabolism disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiogenic shock, cough, hypotension, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, FOLIC ACID, ACETYLSALICYLIC ACID SRT, TITRALAC, ACENOCOUMAROL, ALUCAP. Patient was hospitalized. Patient died on 07/09/2008.


Zemplar Side Effects Report #6032056-7
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 29, 2008. Female patient, weighting 184.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, phosphorus metabolism disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiogenic shock, cough, hypotension, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with EPREX, FILICINE, SALOSPIR, TITRALAC, SINTROM, ALUCAP. Patient was hospitalized. Patient died on 07/09/2008.

Zemplar Side Effects Report #5840981-2
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Aug 01, 2008. Male patient, weighting 138.9 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asphyxia, cough, dyspnoea, hypersensitivity, hypotension, oropharyngeal discomfort. Zemplar dosage: unknown. Patient recovered.

Zemplar Side Effects Report #4843164-8
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Nov 21, 2005. Male patient, weighting 119.0 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, cough, somnolence. Zemplar dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CLOPIDOGREL BISULPHATE, CORVATON RETARD, DREISAVIT N, AMITRIPTYLINE, FENOTEROL HYDROBROMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALORON N RETARD. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #4960155-7
Zemplar side effect was reported by a Physician from GERMANY on Nov 21, 2005. Male patient, weighting 119.0 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain upper, agitation, anaemia, apathy, back pain , blood pressure decreased, c-reactive protein increased, cough, dyspnoea. Zemplar dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CLOPIDOGREL BISULPHATE, CORVATON RETARD, DREISAVIT N, AMITRIPTYLINE HYDROCHLORIDE, FENOTEROL HYDROBROMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALORON N RETARD. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5737573-2
Zemplar side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 171.5 lb, was diagnosed with blood calcium abnormal, blood phosphorus abnormal and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cough. Zemplar dosage: unknown. Patient recovered.


Zemplar Side Effects Report #5737578-1
Zemplar side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 250.2 lb, was diagnosed with blood calcium abnormal, blood phosphorus abnormal and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cough. Zemplar dosage: unknown. Patient recovered.

Zemplar Side Effects Report #5737581-1
Zemplar side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 175.3 lb, was diagnosed with blood calcium abnormal, blood phosphorus abnormal and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cough. Zemplar dosage: unknown. During the same period patient was treated with UNREPORTED. Patient recovered.